RichardJBenjaminMD

PubMed

• 8 citations
  A survey of US hospitals on platelet inventory management, transfusion practice, and platelet availability.
  Suchitra Pandey, Geoffrey A. Belanger, Srijana Rajbhandary, Claudia S. Cohn, Richard J. Benjamin, Arthur Bracey, Louis M. Katz, Jay E. Menitove, Paul D. Mintz, Richard...> ;Transfusion. 2021 Jul 19
• 2 citations
  A conceptual framework for managing iTTP.
  Richard J. Benjamin> ;Blood. 2021 Apr 8
• 18 citations
  Fatal sepsis associated with a storage container leak permitting platelet contamination with environmental bacteria after pathogen reduction
  Emmanuel A. Fadeyi, Stephen J. Wagner, Corinne L. Goldberg, Thea Lu, Pampee P. Young, Peter Bringmann, Nathaniel M Meier, Andrew M. Namen, Richard J. Benjamin, Elizabe...> ;Transfusion. 2021 Feb 1
• 15 citations
  Sepsis from an apheresis platelet contaminated with Acinetobacter calcoaceticus/baumannii complex bacteria and Staphylococcus saprophyticus after pathogen reduction.
  Joy Fridey, Susan L. Stramer, Ashok Nambiar, Morvarid Moayeri, Sonia Bakkour, Charles Langelier, Emily D. Crawford, Thea Lu, Marion C. Lanteri, Jack Kamm, Steve Miller...> ;Transfusion. 2020 Sep 1
• 4 citations
  Prevalence of natural and acquired antibodies to amustaline/glutathione pathogen reduced red blood cells.
  Christof Geisen, Anne North, Lisa Becker, Veronika Brixner, Melissa von Goetz, Laurence Corash, Richard J. Benjamin, Nina Mufti, Erhard Seifried> ;Transfusion. 2020 Jul 21
• 1 citations
  INTERCEPT pathogen-reduced platelets are not associated with higher rates of alloimmunization with (or without) clinical refractoriness in published studies.
  Richard J. Benjamin, Laurence Corash, Philip J. Norris> ;Transfusion. 2020 Apr 1
• 24 citations
  Characterization of Ebola convalescent plasma donor immune response and psoralen treated plasma in the United States.
  Christina L. Dean, Jay W. Hooper, John M. Dye, Samantha E. Zak, Scott A. Koepsell, Laurence Corash, Richard J. Benjamin, Steven A. Kwilas, Shannon Bonds, Anne M. Winkl...> ;Transfusion. 2020 Mar 4
• 17 citations
  Clinical impact of amotosalen-ultraviolet A pathogen-inactivated platelets stored for up to 7 days.
  Laura Infanti, Andreas Holbro, Jakob Passweg, Daniel Bolliger, Dimitrios A. Tsakiris, Ramona Merki, Alexandra Plattner, David Tappe, Johannes Irsch, Jin-Sying Lin, Lau...> ;Transfusion. 2019 Oct 1
• 18 citations
  Proceedings of the Food and Drug Administration public workshop on pathogen reduction technologies for blood safety 2018 (Commentary, p. 3026)
  Chintamani D. Atreya, Simone A. Glynn, Michael P. Busch, Steve Kleinman, Edward A. Snyder, Sara Rutter, James P. AuBuchon, Willy A. Flegel, David A Reeve, Dana Devine,...> ;Transfusion. 2019 Sep 1
• 4 citations
  Acute Zika virus infection in an asymptomatic blood donor at the onset of the Puerto Rico epidemic
  Paula Saá, Charles Y. Chiu, Kacie Grimm, Guixia Yu, Richard J. Benjamin, Laurence Corash, Susan L. Stramer> ;Transfusion. 2019 Aug 13
• 12 citations
  Amustaline-glutathione pathogen-reduced red blood cell concentrates for transfusion-dependent thalassaemia.
  Yesim Aydinok, Antonio Piga, Raffaella Origa, Nina Mufti, Anna Erickson, Anne North, Katie Waldhaus, Christine Ernst, Jin-Sying Lin, Norman Huang, Richard J. Benjamin,...> ;British Journal of Haematology. 2019 Aug 1
• 10 citations
  Transfusion of pathogen-reduced platelet components without leukoreduction.
  Joycelyn Sim, Wai Chiu Tsoi, Cheuk-Kwong Lee, Rock Leung, Clarence C.K. Lam, Claudia Koontz, Amy Yingjie Liu, Norman Huang, Richard J. Benjamin, Hans Vermeij, Adonis S...> ;Transfusion. 2019 Mar 28
• 2 citations
  The argument(s) for lowering the US minimum required content of apheresis platelet components: The argument(s) for lowering the US minimum required content of apheresi...
  Richard J. Benjamin, Lou Katz, Richard R Gammon, Eva Quinley> ;Transfusion. 2019 Apr 1
• 3 citations
  The argument(s) for lowering the US minimum required content of apheresis platelet components.
  Richard J Benjamin, Louis Katz, Richard R Gammon, Susan L Stramer, Eva Quinley> ;Transfusion. 2019 Feb 1
• 17 citations
  Red blood cells treated with the amustaline (S-303) pathogen reduction system: a transfusion study in cardiac surgery.
  Veronika Brixner, AH Kiessling, Katharina Madlener, Markus Müller, Johannes Leibacher, Sarah Dombos, Iuliia Weber, Hans-Ulrich Pfeiffer, Christof Geisen, Michael Schmi...> ;Transfusion. 2018 Apr 1
• 20 citations
  Enlargement of the WHO international repository for platelet transfusion-relevant bacteria reference strains.
  Eva Spindler-Raffel, Richard J. Benjamin, Colin P. McDonald, Sandra Ramirez-Arcos, K. Aplin, Isabelle Bekeredjian-Ding, Dirk de Korte, Christian Gabriel, Birgit S. Gat...> ;Vox Sanguinis. 2017 Sep 27
• 2 citations
  An unbalanced study that lacks power: a caution about IPTAS.
  Richard J. Benjamin, Jin-Sying Lin, Laurence Corash> ;Transfusion. 2017 Sep 1
• 40 citations
  Hemovigilance monitoring of platelet septic reactions with effective bacterial protection systems
  Richard J. Benjamin, Thomas Braschler, Tina Weingand, Laurence Corash> ;Transfusion. 2017 Dec 1
• 27 citations
  Patient outcomes and amotosalen/UVA-treated platelet utilization in massively transfused patients.
  Walter Nussbaumer, M. Amato, Harald Schennach, M. Astl, C. Y. Chen, Jin-Sying Lin, L. Corash, R. J. Benjamin> ;Vox Sanguinis. 2017 Apr 1
• 7 citations
  Plasma treated with amotosalen and ultraviolet A light retains activity for hemostasis after 5 days post-thaw storage at 1 to 6(o) C.
  Anna Erickson, Katie Waldhaus, Tovo David, Norman Huang, Salvador Rico, Laurence Corash, Nina Mufti, Richard J. Benjamin> ;Transfusion. 2017 Apr 1
• 3 citations
  Zika virus in the blood supply.
  Richard J. Benjamin> ;Blood. 2017 Jan 12
• 34 citations
  Impact of platelet pathogen inactivation on blood component utilization and patient safety in a large Austrian Regional Medical Centre.
  M. Amato, Harald Schennach, M. Astl, C. Y. Chen, Jin-Sying Lin, R. J. Benjamin, Walter Nussbaumer> ;Vox Sanguinis. 2017 Jan 1
• 1 citations
  Amotosalen and ultraviolet-A treated platelets and plasma are safe and efficacious in active hemorrhage.
  Richard J. Benjamin, Kent L. Carter, Laurence Corash> ;Transfusion. 2016 Oct 1
• 16 citations
  Investigation of bacterial inactivation in apheresis platelets with 24 or 30 hours between inoculation and inactivation.
  Stephen J. Wagner, Richard J. Benjamin, Cheryl A Hapip, Nadine Kaelber, Annette Turgeon, Andrey Skripchenko, A. Stassinopoulos> ;Vox Sanguinis. 2016 May 17
• 26 citations
  The role of hemovigilance and postmarketing studies when introducing innovation into transfusion medicine practice: the amotosalen-ultraviolet A pathogen reduction tre...
  Laurence Corash, Richard J. Benjamin> ;Transfusion. 2016 Mar 18
• Join now to see all

Abstracts/Posters

• Impact of Amotosalen/UVA Pathogen Inactivated Platelet Components on Outcomes after Allogeneic Hematopoetic Stem Cell Transplantation: A Single Center Analysis
  Richard J. Benjamin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

• A Sequential Cohort Study of Pathogen Reduced Platelet Component Transfusion without Use of Leukocyte Reduction for Hematopoietic Stem Cell Transplant (HSCT): Impact o... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018